Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Acetylon Pharmaceuticals (Cambridge, MA) a clinical-stage developer of selective deacetylase enzyme inhibitors focused on multiple myeloma, closed a $12.4M Series B financing. Participants include NewSpring Health Capital and others.

Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.

Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.

Acetylon Pharmaceuticals (Cambridge, MA) a development-stage small molecule company focused on Histone deacetylase inhibitors for oncology and inflammation indications, closed a $7.2M Series A financing. Participants may include Kraft Group Private Equity.

  

to top of page...